hemlibra
boehringer ingelheim indonesia - indonesia - emicizumab - cairan injeksi - 30 mg/ml
hemlibra
menarini indria laboratories - indonesia - emicizumab - larutan injeksi - 105 mg
hemlibra
menarini indria laboratories - indonesia - emicizumab - larutan injeksi - 150 mg
hemlibra
menarini indria laboratories - indonesia - emicizumab - larutan injeksi - 30 mg
hemlibra
menarini indria laboratories - indonesia - emicizumab - larutan injeksi - 60 mg
feiba
feiba
actemra
boehringer ingelheim indonesia - indonesia - tocilizumab - infus - 20 mg/ml
actemra
boehringer ingelheim indonesia - indonesia - tocilizumab - infus - 20 mg/ml
xolair
novartis indonesia - indonesia - omalizumab - serbuk injeksi - 150 mg